Paracrine-mediated differentiation and activation of human haematopoietic osteoclast precursor cells by skin and gingival fibroblasts

Cell Proliferation

Volumn 44, Issue 3, 2011, Pages 264-273

  Costa Rodrigues, J ^a   Raposo Fernandes, M H ^a  

^a Portugal   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; ANTIBODY; CALVASCULIN; COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; MYC PROTEIN; OSTEOPROTEGERIN; PROTEIN KINASE P60; STREPTOMYCIN;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL CULTURE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FIBROBLAST; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; NONHUMAN; NORMAL HUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PARACRINE SIGNALING; SKIN; STEM CELL;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; FIBROBLASTS; GENE EXPRESSION REGULATION; GINGIVA; HEMATOPOIETIC STEM CELLS; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MODELS, BIOLOGICAL; OSTEOCLASTS; OSTEOPROTEGERIN; PARACRINE COMMUNICATION; RANK LIGAND; SKIN;

EID: 79955414002     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2011.00751.x     Document Type: Article

References (45)

1. Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423, 337-342.
2. Bruzzaniti A, Baron R (2006) Molecular regulation of osteoclast activity. Rev. Endocr. Metab. Disord. 7, 123-139.
3. Vaananen HK, Laitala-Leinonen T (2008) Osteoclast lineage and function. Arch. Biochem. Biophys. 473, 132-138.
4. Datta HK, Ng WF, Walker JA, Tuck SP, Varanasi SS (2008) The cell biology of bone metabolism. J. Clin. Pathol. 61, 577-587.
5. Fries KM, Blieden T, Looney RJ, Sempowski GD, Silvera MR, Willis RA et al. (1994) Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin. Immunol. 72, 283-292.
6. Phipps RP, Borrello MA, Blieden TM (1997) Fibroblast heterogeneity in the periodontium and other tissues. J. Periodontal Res. 32, 159-165.
7. Sorrell JM, Caplan AI (2004) Fibroblast heterogeneity: more than skin deep. J. Cell Sci. 117, 667-675.
8. Kurosu H, Kuro OM (2009) Endocrine fibroblast growth factors as regulators of metabolic homeostasis. Biofactors 35, 52-60.
9. Walsh NC, Crotti TN, Goldring SR, Gravallese EM (2005) Rheumatic diseases: the effects of inflammation on bone. Immunol. Rev. 208, 228-251.
10. Boyce BF, Xing L (2008) Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch. Biochem. Biophys. 473, 139-146.
11. Mundy GR (1996) Bone-resorbing cells. In Research TASfBaM, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, pp. 16-24. Lippincott-Raven Publishers, New York.
12. Osdoby P, Martini MC, Caplan AI (1982) Isolated osteoclasts and their presumed progenitor cells, the monocyte, in culture. J. Exp. Zool. 224, 331-344.
13. Suda T, Takahashi N (1996) Cells of bone: osteoclast generation. In: Bilezikian JP, Rodan GA, eds. Principles of Bone Biology, pp. 87-102. Academic Press, San Diego.
14. Koreny T, Tunyogi-Csapo M, Gal I, Vermes C, Jacobs JJ, Glant TT (2006) The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. Arthritis Rheum. 54, 3221-3232.
15. Kohno S, Kaku M, Tsutsui K, Motokawa M, Ohtani J, Tenjo K et al. (2003) Expression of vascular endothelial growth factor and the effects on bone remodeling during experimental tooth movement. J. Dent. Res. 82, 177-182.
16. Niida S, Kaku M, Amano H, Yoshida H, Kataoka H, Nishikawa S et al. (1999) Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J. Exp. Med. 190, 293-298.
17. Hashizume M, Hayakawa N, Mihara M (2008) IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Rheumatology (Oxford) 47, 1635-1640.
18. Kaku M, Motokawa M, Tohma Y, Tsuka N, Koseki H, Sunagawa H et al. (2008) VEGF and M-CSF levels in periodontal tissue during tooth movement. Biomed. Res. 29, 181-187.
19. Cochran DL, Rouse CA (1993) The effect of conditioned medium from connective tissue fibroblasts and epithelium on calcium release from mouse calvarial organ culture. Arch. Oral Biol. 38, 61-65.
20. de Vries TJ, Schoenmaker T, Wattanaroonwong N, van den Hoonaard M, Nieuwenhuijse A, Beertsen W et al. (2006) Gingival fibroblasts are better at inhibiting osteoclast formation than periodontal ligament fibroblasts. J. Cell. Biochem. 98, 370-382.
21. Saito S, Rosol TJ, Saito M, Ngan PW, Shanfeld J, Davidovitch Z (1990) Bone-resorbing activity and prostaglandin E produced by human periodontal ligament cells in vitro. J. Bone Miner. Res. 5, 1013-1018.
22. Saito S, Saito M, Ngan P, Lanese R, Shanfeld J, Davidovitch Z (1990) Effects of parathyroid hormone and cytokines on prostaglandin E synthesis and bone resorption by human periodontal ligament fibroblasts. Arch. Oral Biol. 35, 845-855.
23. Athanasou NA, Quinn J, Ferguson DJP, McGee JOD (1991) Bone resorption by macrophage polykaryons of giant cell tumour of tendon sheath. Br. J. Cancer 63, 527-533.
24. Codriansky KA, Runger TM, Bhawan J, Kantarci A, Kissin EY (2008) Multicentric reticulohistiocytosis: a systemic osteoclastic disease? Arthritis Rheum. 59, 444-448.
25. Khan ZM, Cockerell CJ (1997) Atypical fibroxanthoma with osteoclast-like multinucleated giant cells. Am. J. Dermatopathol. 19, 174-179.
26. Neale S, Kristelly R, Gundle R, Quinn JMW, Athanasou NA (1997) Giant cells in pigmented villo nodular synovitis express an osteoclast phenotype. J. Clin. Pathol. 50, 605-608.
27. Quinn JM, Horwood NJ, Elliott J, Gillespie MT (2000) Fibroblastic stromal cells express receptor activator of NF-kB ligand and support osteoclast differentiation. J. Bone Miner. Res. 15, 1459-1466.
28. Nicholson GC, Malakellis M, Collier FM, Cameron PU, Holloway WR, Gough TJ et al. (2000) Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL). Clin. Sci. (Lond.) 99, 133-140.
29. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
30. Zhao Q, Shao J, Chen W, Li YP (2007) Osteoclast differentiation and gene regulation. Front. Biosci. 12, 2519-2529.
31. Okada H, Danoff TM, Fischer A, Lopez-Guisa JM, Strutz F, Neilson EG (1998) Identification of a novel cis-acting element for fibroblast-specific transcription of the FSP1 gene. Am. J. Physiol. 275, 306-314.
32. Pixley FJ, Stanley ER (2004) CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol. 14, 628-638.
33. Battaglino R, Kim D, Fu J, Vaage B, Fu XY, Stashenko P (2002) c-myc is required for osteoclast differentiation. J. Bone Miner. Res. 17, 763-773.
34. de Vries TJ, Mullender MG, van Duin MA, Semeins CM, James N, Green TP et al. (2009) The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts. Mol. Cancer Res. 7, 476-488.
35. Logar DB, Komadina R, Preželj J, Ostanek B, Trošt Z, Marc J (2007) Expression of bone resorption genes in osteoarthritis and in osteoporosis. J. Bone Miner. Metab. 25, 219-225.
36. Wada T, Nakashima T, Hiroshi N, Penninger JM (2006) RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol. Med. 12, 17-25.
37. Fuller K, Lean JM, Bayley KE, Wani MR, Chambers TJ (2000) A role for TGFbeta(1) in osteoclast differentiation and survival. J. Cell Sci. 113, 2445-2453.
38. Kaneda T, Nojima T, Nakagawa M, Ogasawara A, Kaneko H, Sato T et al. (2000) Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor. J. Immunol. 165, 4254-4263.
39. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S et al. (2000) Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191, 275-286.
40. Sato K, Takayanagi H (2006) Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr. Opin. Rheumatol. 18, 419-426.
41. Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T et al. (2000) Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum. 43, 259-269.
42. Udagawa N, Kotake S, Kamatani N, Takahashi N, Suda T (2002) The molecular mechanism of osteoclastogenesis in rheumatoid arthritis. Arthritis Res. 4, 281-289.
43. Mandelin J, Li TF, Hukkanen M, Liljestrom M, Salo J, Santavirta S et al. (2005) Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K. J. Rheumatol. 32, 713-720.
44. Sabokbar A, Itonaga I, Sun SG, Kudo O, Athanasou NA (2005) Arthroplasty membrane-derived fibroblasts directly induce osteoclast formation and osteolysis in aseptic loosening. J. Orthop. Res. 23, 511-519.
45. Wei X, Zhang X, Zuscik MJ, Drissi MH, Schwarz EM, O'Keefe RJ (2005) Fibroblasts express RANKL and support osteoclastogenesis in a COX-2-dependent manner after stimulation with titanium particles. J. Bone Miner. Res. 20, 1136-1148.